The metabolic effects of oats intake in patients with Type 2 diabetes: A systematic review and meta-analysis

Nutrients

Volumn 7, Issue 12, 2015, Pages 10369-10387

  Hou, Qingtao ^a   Li, Yun ^b   Li, Ling ^a   Cheng, Gaiping ^a   Sun, Xin ^a   Li, Sheyu ^a   Tian, Haoming ^a  

^a SICHUAN UNIVERSITY   (China)

^b Third People's Hospital of Chengdu   (China)

Author keywords

Cholesterol; Glycemic control; Meta analysis; Oats; Systematic review; Type 2 diabetes mellitus; glucan

Indexed keywords

BETA GLUCAN; CHOLESTEROL; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

AREA UNDER THE CURVE; BLOOD GLUCOSE MONITORING; BODY MASS; CELL FUNCTION; DIET; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN SENSITIVITY; META ANALYSIS; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OAT; OUTCOME ASSESSMENT; PANCREAS ISLET BETA CELL; REVIEW; AVENA; BLOOD; DIET THERAPY; FACTUAL DATABASE; OBSERVATIONAL STUDY; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL (TOPIC);

AVENA; BLOOD GLUCOSE; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 2; DIET; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; OBSERVATIONAL STUDIES AS TOPIC; POSTPRANDIAL PERIOD; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TRIGLYCERIDES;

EID: 84949551750     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7125536     Document Type: Review

References (54)

1. Shaw, J. E.; Sicree, R. A.; Zimmet, P. Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 2010, 87, 4-14. [CrossRef] [PubMed].
2. Zhang, P.; Zhang, X.; Brown, J.; Vistisen, D.; Sicree, R.; Shaw, J.; Nichols, G. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 2010, 87, 293-301. [CrossRef] [PubMed].
3. Evert, A. B.; Boucher, J. L.; Cypress, M.; Dunbar, S. A.; Franz, M. J.; Mayer-Davis, E. J.; Neumiller, J. J.; Nwankwo, R.; Verdi, C. L.; Urbanski, P.; et al. Nutrition therapy recommendations for the management of adults with diabetes. Diabetes Care 2014, 37 (Suppl. S1), S120-S143. [CrossRef] [PubMed].
4. Brennan, C. S. Dietary fibre, glycaemic response, and diabetes. Mol. Nutr. Food Res. 2005, 49, 560-570. [CrossRef] [PubMed].
5. Clemens, R.; van Klinken, B. J. The future of oats in the food and health continuum. Br. J. Nutr. 2014, 112 (Suppl. S2), S75-S79. [CrossRef] [PubMed].
6. El Khoury, D.; Cuda, C.; Luhovyy, B. L.; Anderson, G. H. Beta glucan: Health benefits in obesity and metabolic syndrome. J. Nutr. Metab. 2012, 2012, 851362. [CrossRef] [PubMed].
7. Wang, Q.; Ellis, P. R. Oat β-glucan: Physico-chemical characteristics in relation to its blood-glucose and cholesterol-lowering properties. Br. J. Nutr. 2014, 112, S4-S13. [CrossRef] [PubMed].
8. Food and Drug Administration (FDA), Code of Federal Regulations. Available online: http://www. ecfr. gov/cgi-bin/text-idx?SID=23f8ec3719c5d0e75285aa894ab1e5b0&mc=true&node=se21. 2. 101_181&rgn=div8 (accessed on 14 September 2015).
9. Reyna, N. Y.; Cano, C.; Bermudez, V. J.; Medina, M. T.; Souki, A. J.; Ambard, M.; Nuñez, M.; Ferrer, M. A.; Inglett, G. E. Sweeteners and beta-glucans improve metabolic and anthropometrics variables in well controlled type 2 diabetic patients. Am. J. Ther. 2003, 10, 438-443. [CrossRef] [PubMed].
10. Poppitt, S. D.; van Drunen, J. D.; McGill, A. T.; Mulvey, T. B.; Leahy, F. E. Supplementation of a high-carbohydrate breakfast with barley beta-glucan improves postprandial glycaemic response for meals but not beverages. Asia Pac. J. Clin. Nutr. 2007, 16, 16-24. [PubMed].
11. Weickert, M. O.; Möhlig, M.; Schöfl, C.; Arafat, A. M.; Otto, B.; Viehoff, H.; Koebnick, C.; Kohl, A.; Spranger, J.; Pfeiffer, A. F. Cereal fiber improves whole-body insulin sensitivity in overweight and obese women. Diabetes Care 2006, 29, 775-780. [CrossRef] [PubMed].
12. Guevara-Cruz, M.; Tovar, A. R.; Aguilar-Salinas, C. A.; Medina-Vera, I.; Gil-Zenteno, L.; Hernandez-Viveros, I.; Lopez-Romero, P.; Ordaz-Nava, G.; Canizales-Quinteros, S.; Guillen Pineda, L. E.; et al. A dietary pattern including nopal, chia seed, soy protein, and oat reduces serum triglycerides and glucose intolerance in patients with metabolic syndrome. J. Nutr. 2012, 142, 64-69. [CrossRef] [PubMed].
13. European Food Safety Authority (EFSA). Scientific Opinion on the Substantiation of Health Claims Related to Beta-Glucans and Maintenance or Achievement of Normal Blood Glucose Concentrations (ID 756, 802, 2935) Pursuant to Article 13(1) of Regulation (EC) No 1924/2006. 2010; European Food Safety Authority (EFSA): Parma, Italy, 2010.
14. Oremus, M.; Wolfson, C.; Perrault, A.; Demers, L.; Momoli, F.; Moride, Y. Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer's disease drug trials. Dement. Geriatr. Cogn. Disord. 2001, 12, 232-236. [CrossRef] [PubMed].
15. Wells, G. A.; Shea, B.; O'connell, D.; Peterson, J.; Welch, V.; Losos, M.; Tugwell, P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non randomised studies in meta-analyses. Available online: http://www. ohri. ca/programs/clinical_epidemiology/oxford. asp (accessed on 1 June 2011).
16. Ma, X.; Gu, J.; Zhang, Z.; Jing, L.; Xu, M.; Dai, X.; Jiang, Y.; Li, Y.; Bao, L.; Cai, X.; et al. Effects of Avena nuda L. on metabolic control and cardiovascular disease risk among chinese patients with diabetes and meeting metabolic syndrome criteria: Secondary analysis of a randomized clinical trial. Eur. J. Clin. Nutr. 2013, 67, 1291-1297. [CrossRef] [PubMed].
17. Liatis, S.; Tsapogas, P.; Chala, E.; Dimosthenopoulos, C.; Kyriakopoulos, K.; Kapantais, E.; Katsilambros, N. The consumption of bread enriched with betaglucan reduces LDL-cholesterol and improves insulin resistance in patients with type 2 diabetes. Diabetes Metab. 2009, 35, 115-120. [CrossRef] [PubMed].
18. Cugnet-Anceau, C.; Nazare, J. A.; Biorklund, M.; le Coquil, E.; Sassolas, A.; Sothier, M.; Holm, J.; Landin-Olsson, M.; Onning, G.; Laville, M.; et al. A controlled study of consumption of beta-glucan-enriched soups for 2 months by type 2 diabetic free-living subjects. Br. J. Nutr. 2010, 103, 422-428. [CrossRef] [PubMed].
19. Tappy, L.; Gügolz, E.; Würsch, P. Effects of breakfast cereals containing various amounts of beta-glucan fibers on plasma glucose and insulin responses in NIDDM subjects. Diabetes Care 1996, 19, 831-834. [CrossRef] [PubMed].
20. Jenkins, A. L.; Jenkins, D. J.; Zdravkovic, U.; Würsch, P.; Vuksan, V. Depression of the glycemic index by high levels of beta-glucan fiber in two functional foods tested in type 2 diabetes. Eur. J. Clin. Nutr. 2002, 56, 622-628. [CrossRef] [PubMed].
21. Rendell, M.; Vanderhoof, J.; Venn, M.; Shehan, M. A.; Arndt, E.; Rao, C. S.; Gill, G.; Newman, R. K.; Newman, C. W. Effect of a barley breakfast cereal on blood glucose and insulin response in normal and diabetic patients. Plant Foods Hum. Nutr. 2005, 60, 63-67. [CrossRef] [PubMed].
22. Tapola, N.; Karvonen, H.; Niskanen, L.; Mikola, M.; Sarkkinen, E. Glycemic responses of oat bran products in type 2 diabetic patients. Nutr. Metab. Cardiovasc. Dis. 2005, 15, 255-261. [CrossRef] [PubMed].
23. Yu, K.; Ke, M. Y.; Li, W. H.; Zhang, S. Q.; Fang, X. C. The impact of soluble dietary fibre on gastric emptying, postprandial blood glucose and insulin in patients with type 2 diabetes. Asia Pac. J. Clin. Nutr. 2014, 23, 210-218. [PubMed].
24. Braaten, J. T.; Scott, F. W.; Wood, P. J.; Riedel, K. D.; Wolynetz, M. S.; Brulé, D.; Collins, M. W. High beta-glucan oat bran and oat gum reduce postprandial blood glucose and insulin in subjects with and without type 2 diabetes. Diabet. Med. 1994, 11, 312-318. [CrossRef] [PubMed].
25. Pick, M. E.; Hawrysh, Z. J.; Gee, M. I.; Toth, E.; Garg, M. L.; Hardin, R. T. Oat bran concentrate bread products improve long-term control of diabetes. J. Am. Diet. Assoc. 1996, 96, 1254-1261. [CrossRef].
26. McGeoch, S. C.; Johnstone, A. M.; Lobley, G. E.; Adamson, J.; Hickson, K.; Holtrop, G.; Fyfe, C.; Clark, L. F.; Pearson, D. W.; Abraham, P.; et al. A randomized crossover study to assess the effect of an oat-rich diet on glycaemic control, plasma lipids and postprandial glycaemia, inflammation and oxidative stress in type 2 diabetes. Diabet. Med. 2013, 30, 1314-1323. [CrossRef] [PubMed].
27. Kabir, M.; Oppert, J. M.; Vidal, H.; Bruzzo, F.; Fiquet, C.; Wursch, P.; Slama, G.; Rizkalla, S. W. Four-week low-glycemic index breakfast with a modest amount of soluble fibers in type 2 diabetic men. Metabolism 2002, 51, 819-826. [CrossRef] [PubMed].
28. Ballesteros, M. N.; Valenzuela, F.; Robles, A. E.; Artalejo, E.; Aguilar, D.; Andersen, C. J.; Valdez, H.; Fernandez, M. L. One egg per day improves inflammation when compared to an oatmeal-based breakfast without increasing other cardiometabolic risk factors in diabetic patients. Nutrients 2015, 7, 3449-3463. [CrossRef] [PubMed].
29. Lammert, A.; Kratzsch, J.; Selhorst, J.; Humpert, P. M.; Bierhaus, A.; Birck, R.; Kusterer, K.; Hammes, H. P. Clinical benefit of a short term dietary oatmeal intervention in patients with type 2 diabetes and severe insulin resistance: A pilot study. Exp. Clin. Endocrinol. Diabetes 2008, 116, 132-134. [CrossRef] [PubMed].
30. Zerm, R.; Helbrecht, B.; Jecht, M.; Hein, A.; Millet, E.; Girke, M.; Kroz, M. Oatmeal diet days may improve insulin resistance in patients with type 2 diabetes mellitus. Forsch. Komplement. 2013, 20, 465-468. [CrossRef] [PubMed].
31. Wood, P. J.; Braaten, J. T.; Scott, F. W.; Riedel, K. D.; Wolynetz, M. S.; Collins, M. W. Effect of dose and modification of viscous properties of oat gum on plasma glucose and insulin following an oral glucose load. Br. J. Nutr. 1994, 72, 731-743. [CrossRef] [PubMed].
32. Wolever, T. M.; Vuksan, V.; Eshuis, H.; Spadafora, P.; Peterson, R. D.; Chao, E. S.; Storey, M. L.; Jenkins, D. J. Effect of method of administration of psyllium on glycemic response and carbohydrate digestibility. J. Am. Coll. Nutr. 1991, 10, 364-371. [CrossRef] [PubMed].
33. Stratton, I. M.; Adler, A. I.; Neil, H. A.; Matthews, D. R.; Manley, S. E.; Cull, C. A.; Hadden, D.; Turner, R. C.; Holman, R. R. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study. BMJ 2000, 321, 405-412. [CrossRef] [PubMed].
34. Thies, F.; Masson, L. F.; Boffetta, P.; Kris-Etherton, P. Oats and CVD risk markers: A systematic literature review. Br. J. Nutr. 2014, 112 (Suppl. S2), S19-S30. [CrossRef] [PubMed].
35. Tiwari, U.; Cummins, E. Meta-analysis of the effect of beta-glucan intake on blood cholesterol and glucose levels. Nutrition 2011, 27, 1008-1016. [CrossRef] [PubMed].
36. Whitehead, A.; Beck, E. J.; Tosh, S.; Wolever, T. M. Cholesterol-lowering effects of oat beta-glucan: A meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 2014, 100, 1413-1421. [CrossRef] [PubMed].
37. Stefanick, M. L.; Mackey, S.; Sheehan, M.; Ellsworth, N.; Haskell, W. L.; Wood, P. D. Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol. N. Engl. J. Med. 1998, 339, 12-20. [CrossRef] [PubMed].
38. Ng, D. S. Diabetic dyslipidemia: From evolving pathophysiological insight to emerging therapeutic targets. Can. J. Diabetes 2013, 37, 319-326. [CrossRef] [PubMed].
39. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation 2002, 106, 3143-3421.
40. Singh, R.; De, S.; Belkheir, A. Avena sativa (oat), a potential neutraceutical and therapeutic agent: An overview. Crit. Rev. Food Sci. Nutr. 2013, 53, 126-144. [CrossRef] [PubMed].
41. Battilana, P.; Ornstein, K.; Minehira, K.; Schwarz, J. M.; Acheson, K.; Schneiter, P.; Burri, J.; Jéquier, E.; Tappy, L. Mechanisms of action of beta-glucan in postprandial glucose metabolism in healthy men. Eur. J. Clin. Nutr. 2001, 55, 327-333. [CrossRef] [PubMed].
42. Tosh, S. M. Review of human studies investigating the post-prandial blood-glucose lowering ability of oat and barley food products. Eur. J. Clin. Nutr. 2013, 67, 310-317. [CrossRef] [PubMed].
43. Lyly, M.; Ohls, N.; Lähteenmäki, L.; Salmenkallio-Marttila, M.; Liukkonen, K. H.; Karhunen, L.; Poutanen, K. The effect of fiber amount, energy level and viscosity of beverages containing oat fiber supplement on perceived satiety. Food Nutr. Res. 2010, 54, 2149. [CrossRef] [PubMed].
44. Nazare, J. A.; Normand, S.; Oste Triantafyllou, A.; Brac de la Perriere, A.; Desage, M.; Laville, M. Modulation of the postprandial phase by beta-glucan in overweight subjects: Effects on glucose and insulin kinetics. Mol. Nutr. Food Res. 2009, 53, 361-369. [CrossRef] [PubMed].
45. Rubin, H. The paradox of the contrasting roles of chronic magnesium deficiency in metabolic disorders and field cancerization. Magnes. Res. 2014, 27, 94-102. [PubMed].
46. Chu, Y. F.; Wise, M. L.; Gulvady, A. A.; Chang, T.; Kendra, D. F.; Jan-Willem van Klinken, B.; Shi, Y.; O'Shea, M. In vitro antioxidant capacity and anti-inflammatory activity of seven common oats. Food Chem. 2013, 139, 426-431. [CrossRef] [PubMed].
47. Decker, E. A.; Rose, D. J.; Stewart, D. Processing of oats and the impact of processing operations on nutrition and health benefits. Br. J. Nutr. 2014, 112 (Suppl. S2), S58-S64. [CrossRef] [PubMed].
48. Naumann, E.; van Rees, A. B.; Onning, G.; Oste, R.; Wydra, M.; Mensink, R. P. Beta-glucan incorporated into a fruit drink effectively lowers serum LDL-cholesterol concentrations. Am. J. Clin. Nutr. 2006, 83, 601-605. [PubMed].
49. Amigo, C. D.; Popping, B. Gluten and gluten-free: Issues and considerations of labeling regulations, detection methods, and assay validation. J. AOAC Int. 2012, 95, 337-348. [CrossRef].
50. Ciacci, C.; Ciclitira, P.; Hadjivassiliou, M.; Kaukinen, K.; Ludvigsson, J. F.; McGough, N.; Sanders, D. S.; Woodward, J.; Leonard, J. N.; Swift, G. L. The gluten-free diet and its current application in coeliac disease and dermatitis herpetiformis. United Eur. Gastroenterol. J. 2015, 3, 121-135. [CrossRef] [PubMed].
51. Pourpak, Z.; Mesdaghi, M.; Mansouri, M.; Kazemnejad, A.; Toosi, S. B.; Farhoudi, A. Which cereal is a suitable substitute for wheat in children with wheat allergy? Pediatr. Allergy Immunol. 2005, 16, 262-266. [CrossRef] [PubMed].
52. Frederiksen, B.; Kroehl, M.; Lamb, M. M.; Seifert, J.; Barriga, K.; Eisenbarth, G. S.; Rewers, M.; Norris, J. M. Infant exposures and development of type 1 diabetes mellitus: The diabetes autoimmunity study in the young (daisy). JAMA Pediatr. 2013, 167, 808-815. [CrossRef] [PubMed].
53. Virtanen, S. M.; Takkinen, H. M.; Nevalainen, J.; Kronberg-Kippila, C.; Salmenhaara, M.; Uusitalo, L.; Kenward, M. G.; Erkkola, M.; Veijola, R.; Simell, O.; et al. Early introduction of root vegetables in infancy associated with advanced β-cell autoimmunity in young children with human leukocyte antigen-conferred susceptibility to type 1 diabetes. Diabet Med. 2011, 28, 965-971. [CrossRef] [PubMed].
54. Kleinman, R. E. American Academy of Pediatricsrecommendations for complementary feeding. Pediatrics 2000, 106, 1274. [PubMed].